Medical Science Liaison Rare Diseases Italy
Pubblicato il 12-08-2026 - Recordati in Milano
MedicalScienceLiaison Rare Diseases Italy
Non è sicuro/a delle competenze necessarie per questa opportunità? Legga la descrizione completa qui sotto per avere un quadro completo dei requisiti richiesti.
ID: 2427
Date of Posting: Jun 9, 2026
Business Area: Medical
Job Type: Direct Employee
Full-Time or Part-Time: Tempo pieno
Seniority: Mid-senior
Job Purpose
The Medical Science Liaison, reporting to the Medical Director RRD Italy, serves as the primary scientific interface for the Rare Diseases affiliate in Italy, operating within the pediatric oncology therapeutic area with a specific focus on neuroblastoma, and supporting high-quality scientific exchange, medical education, and field insight generation in a highly complex clinical setting.
Key Responsibilities
-
- Conduct high-quality, timely peer-to-peer scientific exchanges with healthcare professionals, ensuring accurate and balanced communication of scientific data in full compliance with company policies and legal/ethical standards.
- Serve as a trusted scientific partner for clinicians,
providing advanced medical and scientific education, addressing complex clinical questions, and responding to unsolicited requests for information related to disease management and company products.
- Deliver high-level medical education tailored to healthcare professionals’ needs, ensuring scientific rigor and supporting evidence-based clinical decision making in pediatric oncology.
- Act as the medical reference in the field for internal teams and external stakeholders (physicians, pharmacists, institutions), providing expert medical insight on disease area and products.
- Maintain continuous and structured monitoring of the field environment, identifying emerging scientific needs, clinical challenges, and opportunities in real time, and promptly sharing actionable insights with the Medical Department.
- Establish, develop, and maintain strategic relationships with Key Opinion Leaders (KOLs) and key centers involved i